Avita Medical Inc【RCEL】株式ニュース

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery...

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

AVITA Medical Reports First Quarter 2026 Financial Results

VALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

Form 8-K - Current report

AVITA Medical Names Cary Vance as Chief Executive Officer

Board appoints Cary Vance as President and Chief Executive Officer Follows successful interim tenure and...

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

RECELL GO® receives regulatory clearance in Australia and New Zealand, enabling commercialization across both...

AVITA Medical to Announce First Quarter 2026 Financial Results

VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

Recognition highlights pioneering contributions to modern burn care including development of RECELL® Spray-On...

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction)Median time to...

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access...

AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

Cohealyx® multi-center study interim analysis and new case data to be presentedRECELL® and PermeaDerm® data...

Form S-3 - Registration statement under Securities Act of 1933

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading...

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading...

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

makinezmoney 2週前

$RCEL: Good news out.... now $3.90

AVITA Medical reports first U.K. clinical experience with RECELL GO showing successful outcomes and workflow benefits
Case series included 17 U.K. patients treated with RECELL GO, demonstrating successful outcomes and operating-room workflow benefits.
Data were presented at the British Burn Association Annual Meeting as the first documented U.K. clinical experience with RECELL GO.

GO $RCEL

👍️0

SuperLogisticsMan 2月前

$RCEL ... I am back in the stock. I believe the worst is over and that the new CEO will do a great job compared to the 2 previous CEOs.

👍️0

glenn1919 4月前

RCEL..................................................https://stockcharts.com/sc3/ui/?s=RCEL&p=w&b=5&g=0&id=p86431144783

👍️0

MoneyMaker111 6月前

RCEL: $2 ballpark is next on our BINGO board

🔻 1 🟥 1

MoneyMaker111 7月前

RCEL: Not looking good at all. READ WHY:

Still stuck in $3 land: no matter how often bad actors promote this junk. This company here, that misrepresented themselves, is already bankrupted by definition. Household investors don't just risk losing their entire "investment" in this scam [that is being legally investigated in class action, btw, by practically every securities law firm in the country]; they LIKELY WILL lose their entire "investment" in this scam.
As this clown-show joke company hypes and promotes their money-losing business at conferences, it may touch $4 before rolling downhill towards $1 and reverse stock split territory. For any household investors that feel like their products are cool or whatnot, look at their financials. You could give this "avita medical" a miracle product... i.e. a cure for cancer... and the board and C-suite, instead of performing, would indeed find a way to destroy shareholders. Again and again and again.

🔻 1 🟥 1

MoneyMaker111 8月前

RCEL: Financials Reveal Bankruptcy May Be Inevitable

- Negative book value
- Still losing about $50 Million a year
- Revenues are said to have substantially missed estimates
- $36 Million left in working capital
- About $46 Million in debt (and already failing to meet revenue obligations by contract)
- BlackRock revealed by SCHEDULE 13G/A on Friday that they sold about 700,000 shares
- Lawsuits are building (class action) by about 7 reputable law firms against the board who is said to have committed material misrepresentations about the status of their operations and sales expectations

By academic definition in business: Avita Medical's business failed to perform, and is already technically 'bankrupt'. At this point, it would be responsible financially to pull the plug.

$RCEL
#RCEL

🔻 1 🟥 1

Windbag1014 9月前

That's a happy little ball of shit for a Friday.

👍️0

Fmello 9月前

https://spectrumnews1.com/oh/columbus/news/2025/08/11/advanced-technology-decreases-recovery-time-for-burn-survivors

👍️0

renaissance1 10月前

News out. Let’s see if this moves the needle. It is good news IMO.

👍️0

SuperLogisticsMan 11月前

It had a nice run up after it crashed with the earnings announcement. MMs brought it up after financing news. But now, I would be short. IMO.

👍️0

SuperLogisticsMan 11月前

Wow...just wow! Mr. Corbertt needs to leave $RCEL...too many disappointments. I am out and staying out. This might go under a $1 with more disappointments and increased dilution.

👍️0

Fmello 1年前

https://prismmarketview.com/avita-medical-shares-new-clinical-data-showing-cohealyx-speeds-up-wound-healing-for-skin-grafting/

👍️0

Windbag1014 1年前

That's going to leave a mark.

👍️0

Fmello 1年前

When will Avita be able to treat Vitiligo?

👍️0

gasman3 1年前

I'm no expert, but it looks to me like Avita will have to raise cash soon. Financial statements don't look too healthy.

👍️0

Windbag1014 1年前

How much money does RCEL get from the US government for biomed research today?

👍️0

bar1080 1年前

Here come DEEP Trump Cuts to biomed research. Front page news everywhere. Way overdue.

👍️0

SuperLogisticsMan 1年前

$RCEL .... Guess I need to add to my long position on this big drop.

👍️0

pick 2年前

This happened in my backyard. I live near Powhatan and read of the fire. (There are a lot of horse farms around here; Powhatan and Chesterfield counties, where I live are suburds of Richmond, where VCU is located. VCU Hospital was formerly known as the Medical College of Virginia)

It's good PR for Avita, and the widespread used of Recell.

👍️0

Fmello 2年前

Medical director uses new technology to save horse’s skin after massive barn fire

https://www.12onyourside.com/2024/08/02/medical-director-uses-new-technology-save-horses-skin-after-massive-barn-fire/

👍️0

Spetch 2年前

Hi guys, what the hell just happened? We come out with a new product and it drops 10%.

👍️0

Spetch 2年前

Come on bod
Let’s see you put some money where your mouth is As this long-term drop is ridiculous

👍️0

Dretired 2年前

These individual news story need to be developed in all the metropolitan areas throughout the country.

👍️0

Dretired 2年前

Yes good reference post.

👍️0

Spetch 2年前

Hi guys
Would be nice to see some of the board put some money into this would show confidence in the new product
What are your thoughts?

RECELL Go Gets FDA Approval

Massive!!

THIS IS THE WAY.

https://ir.avitamedical.com/news-releases/news-release-details/avita-medical-announces-fda-approval-recell-go

👍️0

believeinsteven 2年前

Morningstar: Avita Medical Shares Remain Undervalued, With Long-Term Opportunity Intact

👍️ 1

Trueheart 2年前

Gratifying? It's my best guess that you're the type that drives by horrible traffic accidents, slowing down to view the carnage, the blood and mangled bodies, just so's you can have something to say that will distract your wife from her crossword puzzle as you're eating dinner.
Be a mensch!

Trueheart

👍️0

Spetch 2年前

Hi all
Would be nice to see the directors making some share buys at these low prices to show confidence in the future

👍️0

Fmello 2年前

https://www.ktnv.com/news/unique-burn-treatment-helps-logandale-girl-recover-nearly-scar-free-at-las-vegas-hospital

As I stated, how he opines is immaterial (despite the fact that he’s on record for liking the company, which is why he had Perry on twice and talked about liking the product many times thereafter). But that was a long time ago. Though positive sentiment never hurts, his “OPINEion” is largely immaterial in the scheme of the facts: FDA approvals, broadening scope, increasing sales, plenty of cash, halo product, and a path to profitability, to mention a few.

And, yes, he does do quite intensive research. He may be wacky, but he’s extremely thorough and highly intelligent. Both he and CNBC have extensive resources and staff that do serious due diligence. I assure you he will see what we ALL see. And he will like A LOT. Maybe all of it. But yes, in the final analysis, he may hedge because of the market cap. Or because they’re not yet profitable though that’s not an intransigent sentiment with him. He mainly holds that position in a risk-off environment with recessionary risk or looming rate hikes as we’ve been in the last couple years.

But these days are different. Have you seen Bitcoin lately? Upcoming IPOs? Anticipated rate cuts? We’re in a very different market than a few months ago and he may change his tune, especially when this company will be profitable by next year. Or he may not. Doesn’t really matter.

No — this is ALL about visibility. Institutions are very well aware of this stock with a couple having taken deep bites, but the retail investor by and a large? I don’t know. This stock is/was mostly held by retail last I checked, but that doesn’t necessarily indicate plurality. Many may have it off their radars these days. Many may just need a couple of positive comments that piques their interest and jives with their risk tolerance. This is who I would expect to come looking. Thousands will look. Some will buy. Maybe small fish. Maybe big fish. There’s no way to know. All I’m saying is “hold on tight.” TiGETTY-tight.

PS: relying “on the new executives executing what seems like a very workable strategy” is in no way shape or form mutually exclusive to gaining massive visibility. Both can be had.

👍️0

MONYMAN3 2年前

I'm afraid he may not opine positively. You know he doesn't recommend stocks that aren't making money? Also, as you say, market cap may not be big enough. If he really did intensive research, I believe he would come out with a positive recommendation. If anything, that would give us a short term pop. Better to rely on the new executives executing what seems like a very workable strategy.

👍️0

Cake10 2年前

Mad Money episode tonight 2/29/24 … on Leap Day of all days.

Caller: Cramer what do you think about Avita Medical?

Cramer: I do not know this company! I will have to do some work.

First of all, the question surprised me. Second, I was surprised they allowed the call to go through as the show, I believe, requires a company to have a minimum market cap of $1B or $1.5B for it to be discussed. He had Mike Perry ON his show twice (once in person) around 2019 or 2020 during its huge run up toward all-time highs when it was around that market cap. He will definitely remember once his staff does their due diligence. This is a FAR more advanced company than it was then.

Usually (maybe always) he’ll do a follow-up with his “homework” updating viewers on questions about stocks on which he was stumped by callers.

This should be VERY interesting, not necessarily because of what he does/doesn’t have to say (you should rely on your own research), but for the mere fact that he has a massive audience and massive platform for visibility.

Hold on VERY tightly to your shares until if/that segment airs, potentially within the next few weeks.

👍️ 1

artfuliving 2年前

Feb 29 (Reuters) - AVITA Medical Inc(RCEL):

* AVITA MEDICAL SUBMITS RESPONSE TO FDA, RESUMING REVIEW CLOCK FOR RECELL GO PMA SUPPLEMENT

* AVITA MEDICAL INC(RCEL) - EXPECT FDA APPROVAL ON MAY 30, 2024, POSITIONING US FOR A PRODUCT LAUNCH ON MAY 31, 2024

Yes!

👍️0

MONYMAN3 2年前

https://ir.enovix.com/events/event-details/journey-scale-podcast-feb-2024-fab2-updates-coo-ajay-marathe

👍️0

MONYMAN3 2年前

https://seekingalpha.com/news/4056668-cantor-picks-rcel-as-best-2024-medtech-idea-bullish-on-pacb-axgn-cers

The Aussie stock closed up 12.59% tonight.

👍️0

Fmello 2年前

https://www-presseportal-de.translate.goog/pm/167421/5687690?_x_tr_sl=de&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

PMI CEO Christian Planck: "We are very pleased that we can now offer RECELL ® in Germany, Austria and Switzerland. Our customers have been asking about this technology for years. In fact, it is a perfect addition to our own portfolio the one- stop shop technology."

"Our partnership with PolyMedics Innovations is the first step in our strategic global expansion," said Jim Corbett, Chief Executive Officer of AVITA Medical. "PMI's proven track record and expertise in the global distribution of innovative wound treatments make them an ideal partner. We look forward to a successful collaboration that will enable us to reach more patients worldwide."

👍️0

MONYMAN3 3年前

https://us02web.zoom.us/rec/play/D_NT2rl2dZcpc7L_XUt6VJh81E_HIM21mngBXR6KjZHRPs0VCBfzNWiyCOb7vHVaubUpQSvF7WhSZaPB.oSXXXZT66WOzvHuC?hasValidToken=false&canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2FDh9UFDWQhFjYF0S9afouXwsCKphzVngmXyS6lDfdDuXYk52XXdCrVctLIq0WiYkA.PO58b8CAaqc_JBTL RCEL Investor Webinar

👍️0

Fmello 3年前

Here's a detailed presentation about Recell.
(warning: some of the pics are very graphic)

https://avitamedical.showpad.com/share/NAPlEVouN92Enz79yKX4z

👍️0

believeinsteven 3年前

“We have achieved significant commercial revenue growth rates for
the last three quarters of 40%, 42% and 51%, respectively, over the
same periods in the previous year,” said David O’Toole, Chief
Financial Officer of AVITA Medical. “Further, we remain confident
that our cash reserves position us to achieve our goals and reach
profitability in 2025.”

👍️0

Spetch 3年前

Hi
Not the worst results ever moving forward

👍️0

artfuliving 3年前

He's just making the rounds with another "told you so" post. 🎱🦨 😄

👍️0

Windbag1014 3年前

You're back.
Pull all the wings off the flies? Lots of legless grasshoppers in your neighborhood. No dead people to pick on? Oh the gratification.

👍️0

bar1080 3年前

Gratifying watching much "Perpetual Startup" crap collapsing. Thinking of Plug Power, LWLG (Lightwave Logic), SolarWindow, Liquidmetal.... and maybe several hundred more. This market rewards large caps with audited profits and regular cash dividends. Bad news for IHUB and its dead stock boards and company insiders drawing monstrously large wages for running itty bitty penny stocks where success is always "just around the corner."

Also: "Wow, I see this board is >ten years old. I don't buy tiny biomed stocks. Most are perpetual startups. Vapor. I require GAAP profits and usually dividends.
But I make money with my investments." https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171926857

👍️0

Spetch 3年前

Why the total free fall of share price
Any comments
Thanks steve

👍️0

Align 3年前

Apologies, it looks like I was wrong about preliminary results.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Avita Medical Inc (RCEL)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Avita Medical Inc (RCEL) ニュース

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Reports First Quarter 2026 Financial Results

Form 8-K - Current report

AVITA Medical Names Cary Vance as Chief Executive Officer

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

AVITA Medical to Announce First Quarter 2026 Financial Results

AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

Form S-3 - Registration statement under Securities Act of 1933

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

RCEL Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Avita Medical Inc (RCEL)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Avita Medical Inc (RCEL) ニュース

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Reports First Quarter 2026 Financial Results

Form 8-K - Current report

AVITA Medical Names Cary Vance as Chief Executive Officer

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

AVITA Medical to Announce First Quarter 2026 Financial Results

AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

Form S-3 - Registration statement under Securities Act of 1933

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

RCEL Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する